Special Issue "Recent Advances in Papillomaviruses Research"
Deadline for manuscript submissions: 31 October 2021.
Persistent infections with high risk human papillomaviruses (HPV) account for more than 600.000 newly diagnosed cancers of the anogenital and oropharyngeal tract annually. Although much information has been gathered from laboratory and clinical investigations, we still have an incomplete picture of the critical interactions of HPV with host cells and the immune system. This Special Issue on Recent Advances in Papillomaviruses Research in Viruses will provide a multifaceted view of the latest research into papillomaviruses. Each chapter in this series will highlight the efforts and progress made to acquire basic knowledge of HPV host interactions and will indicate particular areas that remain to be uncovered. Topics in this new series include the processes of HPV entry into keratinocytes, HPV and the DNA damage response, BRD4 proteins in the HPV life cycle, different animal papillomavirus model systems as well as updates on L2- based prophylactic vaccines and on improved HPV diagnostics.
Prof. Dr. Thomas Iftner
Prof. Dr. Frank Stubenrauch
- virus entry
- DNA Damage response
- HPV diagnostics
- animal models